World Journal of Clinical Cases - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Supple W. Letter to the Editor: Fenbendazole liver enzyme elevation in checkpoint inhibitor-treated patients as benzimidazole potentiated immunogenic tumor cell death. World J Clin Cases 2026; 14(25): 124046 [DOI: 10.12998/wjcc.124046]
URL:	https://www.wjgnet.com/2307-8960/full/v14/i25/124046.htm

(33) (30) (0) (0) (0) (1) (478) (1)

Number	Citing Articles
1	Arunkumar Krishnan, Tinsay A Woreta. Letter to the Editor: Hepatocellular pattern is compatible with fenbendazole-associated drug-induced liver injury. World Journal of Clinical Cases 2026; 14(27): 127697 doi: 10.12998/wjcc.127697 Abstract(23) \| Core Tip(20) \| Full Article(HTML)(100) \| Full Article (PDF)-344K(10) \| Full Article with Cover (PDF)-699K(9) \| Full Article (XML)-24K(7) \| Audio-829K(4) \| Peer-Review Report-215K(11) \| Answering Reviewers-130K(8) \| Times Cited (0) \| Total Visits (126) \| Open

Number

Citing Articles

Arunkumar Krishnan, Tinsay A Woreta. Letter to the Editor: Hepatocellular pattern is compatible with fenbendazole-associated drug-induced liver injury. World Journal of Clinical Cases 2026; 14(27): 127697 doi: 10.12998/wjcc.127697

Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.